Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

CSE/BUX stock hub

CSE/BUX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/BUXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

66.4M

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/BUX

In the news

Latest news · CSE/BUX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROEn/a

P25 -121.5P50 -40.9P75 0.5

ROIC-152.6

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/BUX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

162

Groups with data

Currency

CAD

Showing 162 of 162 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 65.8M
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Diagnostics & Research
Isin	CA09073K1084
Last refreshed	2026-05-10
Market cap	CAD 66.4M
Price	CAD 0.58
Price currency	CAD
Sector	Healthcare
Sic	2836
Symbol	cse/BUX
Website	https://www.biomarkdiagnostics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.56%
EV Earnings	-38.71x
EV/FCF	-32.09x
FCF yield	-3.09%
P/B ratio	130.65x
P/S ratio	723.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	CAD 91,771
Gross Profit Growth	-40.8%
Gross Profit Growth Q	-82.07%
Gross Profit Growth3 Y	-12.69%
Net Income	CAD -1.7M
Net Income Growth Years	0%
Pretax Margin	-1,852.06%
ROA	-81.7
Roa5y	-85.84
ROCE	-218.4
ROIC	-152.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	15.7%
Cagr1y	107.25%
Cagr3y	29.02%
Cagr5y	5.68%
EPS Growth Quarters	3
EPS Growth Years	0
Revenue Growth	-40.8x
Revenue Growth Q	-82.07x
Revenue Growth Years	0x
Revenue Growth3 Y	-12.69x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.06
Assets	CAD 2.1M
Cash	CAD 1.3M
Current Assets	CAD 1.5M
Current Liabilities	CAD 1.2M
Debt	CAD 711,779
Debt Equity	CAD 1.4
Debt FCF	CAD -0.35
Equity	CAD 508,033
Interest Coverage	-39.96
Liabilities	CAD 1.6M
Long Term Assets	CAD 657,909
Long Term Liabilities	CAD 393,415
Net Cash	CAD 574,407
Net Cash By Market Cap	CAD 0.87
Net Debt Equity	CAD -1.13
Tangible Book Value	CAD 508,033
Tangible Book Value Per Share	CAD 0
WACC	2.68

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.2
Net Working Capital	CAD -724,283
Quick ratio	1.2
Working Capital	CAD 243,539
Working Capital Turnover	CAD -0.16

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	84.66%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	329.63%
1Y total return	107.14%
200-day SMA	0.43
3Y total return	114.82%
50-day SMA	0.59
50-day SMA vs 200-day SMA	50over200
5Y total return	31.82%
All Time High	0.64
All Time High Change	-9.38%
All Time High Date	2026-03-03
All Time Low	0.03
All Time Low Change	2,220%
All Time Low Date	2016-10-17
ATR	0.02
Beta	-0.29
Ch YTD	23.4
High	0.59
High52	0.64
High52 Date	2026-03-03
High52ch	-9.38%
Low	0.54
Low52	0.26
Low52 Date	2025-05-21
Low52ch	123.08%
Ma50ch	-0.99%
Price vs 200-day SMA	34.63%
RSI	48.29
RSI Monthly	77.66
RSI Weekly	63.8
Sharpe ratio	1.91x
Sortino ratio	3.37
Total Return	84.66%
Tr YTD	23.4
Tr1m	-3.33%
Tr1w	-1.69%
Tr3m	16%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -2M
Operating margin	-2,145.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	48,265,682%
Net Borrowing	340,392
Shares Insiders	12.5%
Shares Qo Q	0%
Shares Yo Y	-84.66%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -2.1M
Average Volume	4,441.25x
Bv Per Share	0
CAPEX	CAD -629,165
Ch10y	329.6
Ch1m	-3.33
Ch1w	-1.69
Ch1y	107.1
Ch3m	16
Ch3y	114.8
Ch5y	31.82
Ch6m	68.12
Change	-1.69%
Change From Open	-1.69
Close	0.59
Days Gap	0
Depreciation Amortization	15,956
Dollar Volume	9,918
Earnings Date	2026-07-29
EBIT	CAD -2M
EBITDA	CAD -2M
EPS	CAD -0.02
F Score	2
FCF	CAD -2.1M
FCF EV Yield	-3.12x
Financing CF	3,247,818
Fiscal Year End	March
Founded	2,014
Investing CF	-1,427,651
Is Primary Listing	0
Last Earnings Date	2026-02-26
Last Report Date	2025-12-31
Ma150	0.46
Ma150ch	25.16%
Ma20	0.59
Ma20ch	-1.11%
Net CF	399,117
Next Earnings Date	2026-07-29
Open	0.59
Position In Range	80
Ppne	604,337
Price Date	2026-05-08
Ptbv Ratio	130.7
Relative Volume	4.17x
Revenue	91,771x
SBC By Revenue	81.41x
Share Based Comp	74,714
Tr6m	68.12%
Volume	17,100
Z Score	-3.64

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/BUX pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/BUX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CSE/BUX?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+12.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-84.7%

Negative means the company is buying back shares.

Technical

CSE/BUX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.3

Neutral momentum band

Price vs 200-day MA

+34.6%

50/200-day relationship not available

Beta (5Y)

-0.29

Less volatile than the market

Sharpe ratio

1.91

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/BUX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/BUX stock rating?

cse/BUX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/BUX analysis?

The full report lives at /stocks/cse/BUX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/BUX?

The latest report frames cse/BUX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/BUX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.